SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934


DelMar Pharmaceuticals, Inc.
(Name of Issuer)

Common Stock, $.001 par value per share
(Title of Class of Securities)

247078108
(CUSIP Number)

January 25, 2013
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[_] Rule 13d-1(b)

[X] Rule 13d-1(c)

[_] Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities and Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


Persons who respond to the collection of information contained in this form are not required to respond unless the forms displays a currently valid OMB control number
 
 
 
 
1
 
 
 
CUSIP No. 247078108
 
13G
  
     
1
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
  
     
 
Donald G. Bahouth
  
2
CHECK THE APPROPRIATE BOX IF MEMBER OF A GROUP
  
   
(a) o
   
(b) o Reporting person is affiliated with other persons
3
SEC USE ONLY
  
     
     
4
CITIZENSHIP OR PLACE OF ORGANIZATION
  
     
 
United States of America
  
 
5
SOLE VOTING POWER
     
 
  
2,085,000*
NUMBER OF
6
SHARED VOTING POWER
SHARES
    
BENEFICIALLY
  
0
OWNED BY
7
SOLE DISPOSITIVE POWER
EACH REPORTING
    
PERSON WITH
  
2,085,000*
 
8
SHARED DISPOSITIVE POWER
     
 
  
0
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
  
     
 
2,085,000*
  
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
  
     
   
o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
  
     
 
11.18%*
  
12
TYPE OF REPORTING PERSON
  
     
 
IN
  

     
*See Item 4 – Ownership.


 
2
 
 
ITEM 1.  SECURITY AND ISSUER.

(a)  
Name of Issuer:

DelMar Pharmaceuticals, Inc.
 
 
(b)  
Address of Issuer:

Suite 720-999 West Broadway
Vancouver, British Columbia
Canada V5Z 1K5

ITEM 2.  IDENTITY AND BACKGROUND.
 
 
Item 2(a).   Name of Person Filing:
   
  This statement is being filed by Mr. Donald G. Bahouth (the “Reporting Person”).
   
Item 2(b)    Address of Principal Business Office or, if none, Residence:
   
  Reporting Person, a United States citizen, has a business address at 1059 Grand Heron Crt. West, Mobile, AL 36693
   
Item 2(c).    Citizenship:
   
  Reporting Person is a United States citizen.
   
Item 2(d).   Title of Class of Securities:
   
  Common Stock, par value $.001 per share.
   
Item 2(e).   CUSIP Number:
   
  247078108

Item 3.  If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 
(a)
o
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
       
 
(b)
o
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
       
 
(c)
o
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
       
 
(d)
o
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
       
 
(e)
o
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
       
 
(f)
o
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
       
 
(g)
o
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
       
 
(h)
o
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
 
(i)
o
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
       
 
(j)
o
Group, in accordance with §240.13d-1(b)(1)(ii)(J).
 
 
 
3
 

 
ITEM 4.  OWNERSHIP

a)
Amount beneficially owned:    
 
 
Reporting Person
  
Shares
  
Donald Bahouth
  
2,085,000
  
 
 
(b)
Percent of class:   
 
 
Reporting Person
  
Percent
  
Donald Bahouth
  
11.18
%
  
 
(c)
Number of shares as to which the person has:
 
   
(i)
Sole power to vote or to direct the vote with respect to each Reporting Person

Reporting Person
  
Shares
  
Donald Bahouth
  
2,085,000
  

   
(ii)
Shared power to vote or to direct the vote    
-0-
                                                                                               
 
   
(iii)
Sole power to dispose or to direct the disposition of with respect to each Reporting Person

Reporting Person
  
Shares
  
Donald Bahouth
  
2,085,000
  

   
(iv)
Shared power to dispose or to direct the disposition of   
-0-
 
 
 
 
 
4
 
 
Consists of (i) 1,042,500 shares of common stock; and (ii) 1,042,500 shares of common stock issuable upon the exercise of warrants.

ITEM 5.   
OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:

Not applicable.


ITEM 6.
OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
 
Not applicable.



ITEM 7.
IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
 
Not applicable.


ITEM 8.
IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
 
Not applicable.


ITEM 9.   
NOTICE OF DISSOLUTION OF GROUP:
 
Not applicable.
 
ITEM 10.  
CERTIFICATION:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose or with the effect of changing or influencing the control of the issuer of the securities and were not acquired or held in connection with or as a participant in any transaction having that purpose or effect.

 
5
 


 
SIGNATURES

 After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and accurate.
 
     
   
     
February 1, 2013
By: 
/s/ Donald Bahouth
 
Name: Donald G. Bahouth
   
 


 
 
 
6